Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration

Contrib Nephrol. 1991:93:215-7. doi: 10.1159/000420222.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Anticoagulants / therapeutic use*
  • Benzamidines
  • Guanidines / adverse effects
  • Guanidines / pharmacokinetics
  • Guanidines / therapeutic use*
  • Hemofiltration*
  • Hemorrhage / chemically induced
  • Hemorrhage / epidemiology
  • Heparin / adverse effects
  • Heparin / pharmacokinetics
  • Heparin / therapeutic use
  • Heparin, Low-Molecular-Weight / adverse effects
  • Heparin, Low-Molecular-Weight / pharmacokinetics
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Incidence
  • Renal Dialysis*

Substances

  • Anticoagulants
  • Benzamidines
  • Guanidines
  • Heparin, Low-Molecular-Weight
  • Heparin
  • nafamostat